Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Endobronchial ultrasound
Devanand Anantham ... Armin Ernst
Respiratory Medicine | VOL. 103
Devanand Anantham, et. al.Devanand Anantham ... Armin Ernst
15 May 2009
Second-Line Chemotherapy for Non-small Cell Lung Cancer
John C Ruckdeschel
Chest | VOL. 129
John C RuckdeschelJohn C Ruckdeschel
01 Apr 2006
The Challenges of Third-Generation EGFR Tyrosine Kinase Inhibitors in the Therapy of Advanced NSCLC
Fen Wang ... Qing Zhou
Journal of Thoracic Oncology | VOL. 17
Fen Wang, et. al.Fen Wang ... Qing Zhou
17 Mar 2022
View more papers

More From: BMJ Open Respiratory Research

Paper Title
Journal
Date
Author
Twelve barriers to COPD diagnosis in France: a comparative qualitative study
Guillaume Roucoux ... Maéva Zysman
BMJ Open Respiratory Research | VOL. 12
Guillaume Roucoux, et. al.Guillaume Roucoux ... Maéva Zysman
22 Jan 2025
Retrospective cross-sectional study on bronchiectasis in adult Aboriginal Australians: disease characteristics and comparison with ethnically diverse global bronchiectasis registry cohorts
Subash Heraganahally ... Timothy Howarth
BMJ Open Respiratory Research | VOL. 12
Subash Heraganahally, et. al.Subash Heraganahally ... Timothy Howarth
21 Jan 2025
Protocol for the enhanced management of multimorbid patients with COPD and severe asthma: role of indoor air quality
Alba Gómez-López ... Rubèn González-Colom
BMJ Open Respiratory Research | VOL. 12
Alba Gómez-López, et. al.Alba Gómez-López ... Rubèn González-Colom
20 Jan 2025
Real-world clinical utility of Xpert MTB/RIF Ultra in the assessment of tuberculosis in a low-TB-incidence, high-resource setting
Jee Whang Kim ... Pranabashis Haldar
BMJ Open Respiratory Research | VOL. 12
Jee Whang Kim, et. al.Jee Whang Kim ... Pranabashis Haldar
19 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.